Hot Features
プレミアム
Amneal Pharmaceuticals Inc (AMRX)
NASDAQ
登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。
| 日付 | 保有者名 | 取引株数 | 金額レンジ ($) | 取引種別 | 価格レンジ ($) | 届出終了時の株数 | % 変化 |
|---|---|---|---|---|---|---|---|
| 2026-05-11 | Ms. Deborah M. AutorIndependent Director | -34.82k | 450.56k | 売り | 12.94 | 93.66k | -27.10% |
| 2026-05-07 | Mr. J. Kevin BuchiIndependent Director | 34.82k | 0.00 | Derivative Exercise and Retained Stock | - | 337.15k | 11.52% |
| 2026-05-07 | Ms. Deborah M. AutorIndependent Director | 34.82k | 0.00 | Derivative Exercise and Retained Stock | - | 128.48k | 37.18% |
| 2026-05-07 | Mr. Jeffrey P. GeorgeIndependent Director | 34.82k | 0.00 | Derivative Exercise and Retained Stock | - | 344.61k | 11.24% |
| 2026-05-07 | Mr. Gautam PatelDirector | 34.82k | 0.00 | Derivative Exercise and Retained Stock | - | 1.64M | 2.16% |
| 2026-05-07 | Mr. John J. KielyIndependent Director | 34.82k | 0.00 | Derivative Exercise and Retained Stock | - | 260.25k | 15.45% |
| 2026-05-07 | Mr. Ted C. NarkIndependent Director | 34.82k | 0.00 | Derivative Exercise and Retained Stock | - | 325.85k | 11.96% |
| 2026-05-07 | Mr. Paul M. MeisterIndependent Chairman of the Board | 48.75k | 0.00 | Derivative Exercise and Retained Stock | - | 832.80k | 6.22% |
| 2026-05-07 | Mr. Shlomo YanaiIndependent Director | 34.82k | 0.00 | Derivative Exercise and Retained Stock | - | 320.80k | 12.18% |
| 2024-11-14 | Dipan Patelインサイダー | -6.92M | 86.01M | 売り | 7.74 - 12.42 | 16.90M | -29.06% |
| 2026-03-03 | Mr. Chirag K. PatelCo-Founder, Co-CEO, President & Director | 535.49k | 0.00 | Derivative Exercise and Retained Stock | - | 22.66M | 2.42% |
| 2026-03-03 | Mr. Chirag K. PatelCo-Founder, Co-CEO, President & Director | -350.98k | 4.67M | Derivative Exercise and Sale | 13.30 - 13.31 | 22.66M | - |
| 2026-03-03 | Mr. Chintu PatelCo-Founder, Co-CEO & Director | 524.49k | 0.00 | Derivative Exercise and Retained Stock | - | - | - |
| 2026-03-03 | Mr. Chintu PatelCo-Founder, Co-CEO & Director | -361.98k | 4.82M | Derivative Exercise and Sale | 13.30 - 13.31 | - | - |
| 2026-03-03 | Mr. Jason B. DalyExec. VP, Chief Legal Officer & Corporate Secretary | 241.18k | 0.00 | Derivative Exercise and Retained Stock | - | 251.78k | 2,273.98% |
| 2026-03-03 | Mr. Jason B. DalyExec. VP, Chief Legal Officer & Corporate Secretary | -185.64k | 2.47M | Derivative Exercise and Sale | 13.30 - 13.31 | 251.78k | - |
| 2026-03-03 | Mr. Anastasios G. KonidarisExec. VP & CFO | 327.28k | 0.00 | Derivative Exercise and Retained Stock | - | 449.43k | 267.93% |
| 2026-03-03 | Mr. Anastasios G. KonidarisExec. VP & CFO | -306.58k | 4.08M | Derivative Exercise and Sale | 13.30 - 13.31 | 449.43k | - |
| 2026-03-03 | Ms. Nikita ShahExec. VP & Chief HR Officer | 253.39k | 0.00 | Derivative Exercise and Retained Stock | - | 399.79k | 173.08% |
| 2026-03-03 | Ms. Nikita ShahExec. VP & Chief HR Officer | -255.11k | 3.40M | Derivative Exercise and Sale | 13.30 - 13.31 | 399.79k | - |
| 2026-03-03 | Mr. Andrew S. BoyerExec. VP and Chief Commercial Officer of Generics & Biosciences | 273.65k | 0.00 | Derivative Exercise and Retained Stock | - | 426.07k | 179.53% |
| 2026-03-03 | Mr. Andrew S. BoyerExec. VP and Chief Commercial Officer of Generics & Biosciences | -275.31k | 3.66M | Derivative Exercise and Sale | 13.30 - 13.31 | 426.07k | - |
| 2025-11-17 | Mr. Ted C. NarkIndependent Director | -50.00k | 586.00k | 売り | 11.72 | 291.03k | -14.66% |
| 2025-11-12 | Ms. Nikita ShahExec. VP & Chief HR Officer | -131.86k | 1.21M | Derivative Exercise and Sale | 2.75 - 11.92 | 146.40k | - |
| 2025-10-03 | Mr. Chintu PatelCo-Founder, Co-CEO & Director | 13.26M | 0.00 | 買い | - | 25.62M | 107.26% |
| 2025-10-03 | Mr. Chintu PatelCo-Founder, Co-CEO & Director | -13.26M | 0.00 | 売り | - | 25.62M | -34.10% |
| 2025-08-27 | Mr. John J. KielyIndependent Director | -32.00k | 295.36k | 売り | 9.23 | 225.43k | -12.43% |
| 2025-08-22 | Ms. Nikita ShahExec. VP & Chief HR Officer | -120.83k | 1.17M | 売り | 9.50 - 9.66 | 146.40k | -45.22% |
| 2025-08-20 | Mr. Andrew S. BoyerExec. VP and Chief Commercial Officer of Generics & Biosciences | -175.00k | 1.16M | Derivative Exercise and Sale | 2.75 - 9.38 | 152.43k | - |
| 2025-08-20 | Mr. Andrew S. BoyerExec. VP and Chief Commercial Officer of Generics & Biosciences | -104.24k | 977.81k | 売り | 9.38 | 152.43k | -40.61% |
| 2025-08-14 | Ms. Nikita ShahExec. VP & Chief HR Officer | -71.69k | 666.04k | 売り | 9.29 | 267.24k | -21.15% |
| 2025-08-13 | Mr. Anastasios G. KonidarisExec. VP & CFO | -499.73k | 4.66M | 売り | 9.22 - 9.43 | 122.15k | -80.36% |
| 2025-08-12 | Ms. Nikita ShahExec. VP & Chief HR Officer | -50.00k | 452.00k | 売り | 9.04 | 338.93k | -12.86% |
| 2025-08-12 | Mr. Jason B. DalyExec. VP, Chief Legal Officer & Corporate Secretary | -22.00k | 199.10k | 売り | 9.05 | 10.61k | -67.47% |
| 2025-08-12 | Mr. Andrew S. BoyerExec. VP and Chief Commercial Officer of Generics & Biosciences | -33.44k | 302.60k | 売り | 9.05 | 256.67k | -11.53% |
| 2025-06-16 | Mr. Gautam PatelDirector | -94.91k | 761.15k | Automatic Disposition | 8.02 | 1.61M | -5.57% |
| 2025-06-10 | Mr. Gautam PatelDirector | -56.43k | 452.54k | 売り | 8.02 | 1.70M | -3.21% |
ご覧いただいた銘柄が下記のボックス内に表示されますので、過去閲覧した銘柄情報に簡単にアクセスすることができます。
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約
メールアドレスで登録
すでにアカウントをお持ちですか？ サインイン
アカウントをお持ちでないですか？ 登録
登録することで、ADVFN の 利用規約 を読み、理解し、同意したこと、および私が個人投資家であることを確認します。
